Weight loss drugs give women with PMOS new hope in fight against hormonal disorder An expanding body of research indicates that these anti-obesity drugs may also work for the disorder known as PMOS The Independent UK · Aug 15
From 1996 to 2021, nearly three million women in Utah Population Database were tracked by researchers, new study shows shocking results related to type 2 diabetes The association between endometriosis and a higher diabetes risk was strongest among premenopausal women and women without obesity -- groups not traditionally considered at the highest risk for type 2 diabetes, the researchers said. The Economic Times · Aug 14
Britain’s quarter century: experts in sex, mental health, nutrition and addiction assess the nation’s changing wellbeing In this fourth part in our series on how the UK has changed in the past 25 years, we look at health. The Conversation · Aug 14
An Obesity Shot No Regulator Has Ever Approved Is Being Sold at Medical Spas Across the Country Retatrutide is not approved anywhere in the world, yet clinics and med spas sell it. Poison center exposures rose 265 percent in early 2026. Medical Daily · Aug 14
Dietary Fat Raised a Brain Protein in Male Mice but Not Females, and an Obesity Drug Then Worked Less Well A mitochondrial protein rose in appetite neurons when male mice drank oil but not in females, and deleting it drove obesity in mice. Medical Daily · Aug 14
8 Warning Signs of Pancreatic Problems That Most Indians Miss Before It's Too Late 1. Pain That Sits Between Your Shoulder BladesThe pancreas sits deep behind the stomach, tucked against the spine. When it inflames or a tumour begins to grow, the pain often radiates to the mid-back or between the shoulder blades rather than the abdomen. Most people reach for a pain balm.… Times Life · Aug 14
5 Common Daily Habits That Quietly Raise Your Gallstone and Cholesterol Risk Before 50 Skipping Meals, Especially BreakfastWhen the gallbladder sits idle for long periods, bile, the digestive fluid it stores, becomes concentrated. Concentrated bile is exactly the environment in which cholesterol crystals begin to form. A 2013 study published in the American Journal of Gastroenterology found that fasting for more than 14 hours… Times Life · Aug 14
What Skipping Meals Does to Your Gallbladder: Bile, Stones, and the Fasting Risk The Gallbladder Is Not a Storage Organ You Can IgnoreThe gallbladder's job is timed release. It holds bile produced by the liver and squeezes it into the small intestine the moment fat enters from a meal. That squeeze is triggered by eating. No meal, no squeeze. Bile sits. And bile… Times Life · Aug 14
Why Gallstones Are Striking Indian Women Under 40: Diet, Hormones, and Rising Risk The hormonal connection is directGallstones are forming in Indian women in their twenties and early thirties at rates that would have been unusual a generation ago. A 2018 study published in the Indian Journal of Gastroenterology found gallstone prevalence in Indian women significantly higher than in men, with urban women… Times Life · Aug 13
The Obesity Drug Race Moves Past Ozempic with a Shot Targeting Three Hormones Eli Lilly's retatrutide produced up to 30.3% average weight loss in phase 3 trials. Approval is not expected before 2027 at the earliest. Medical Daily · Aug 11
RFK Jr takes aim at ‘unvetted’ ingredients in US food supply with new FDA proposal Neither of Monday's announcements are likely to immediately impact American diets, which are blamed for a host of chronic diseases such as obesity, diabetes and heart disease The Independent UK · Aug 10
What doctors want everyone to know about CKM syndrome - a condition that 90% of Americans face This extremely common and life-threatening condition connects the biggest areas of your health The Independent UK · Aug 10
Nearly a Third of Women Under 45 Are Projected to Have Cardiovascular Disease Within 25 Years An American Heart Association statement projects nearly a third of women aged 20 to 44 will have cardiovascular disease by 2050, up from under a quarter. Medical Daily · Aug 10
Psoriasis and Heart Disease Risk: What the Inflammation Link Means for Your Cardiovascular Health The inflammation that shows on your skin is also inside your arteriesPsoriasis is classified as a systemic autoimmune disease, which means the immune malfunction behind your skin plaques is not confined to the surface. The same cytokines, particularly TNF-alpha, IL-17, and IL-23, that drive skin inflammation also accelerate atherosclerosis, the… Times Life · Aug 9
Medical Daily · Aug 8 The Effects That Patients Experience When They Stop Taking GLP-1 Weight-Loss Drugs Amazon's $50 Medicare GLP-1 offer may expand access to weight-loss drugs, while research showcases weight regain and appetite changes after treatment stops.
Medical Daily · Aug 6 Retatrutide Will Not Reach the FDA Until Early 2027, Leaving No Price and No Coverage Decision to Point To Lilly will not file retatrutide with the FDA until early 2027. What that delay means for cost, insurance coverage, and patients considering waiting.
Barchart · Aug 6 Eli Lilly Stock: Analyst Estimates & Ratings Eli Lilly's market-beating performance has done little to temper Wall Street's optimism, with analysts continuing to see meaningful upside in the stock.
International Business Times · Aug 5 Bank of America CEO Says The Company Spends $250 Million A Year on GLP-1 Drugs for Their Employees. He Calls It a Good Investment Bank of America CEO Brian Moynihan said the company has dramatically increased its investment in medications such as Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Zepbound.
Medical Daily · Aug 5 Lost Weight but Gained It Back? Scientists Say Your Brain May Be Secretly Working Against You New research suggests the brain may "remember" your highest weight and fight to regain it after weight loss, shedding light on why dieting often fails and how drugs like Wegovy and Mounjaro may help.
Benzinga · Aug 5 Eli Lilly's Weight-Loss Empire Keeps Expanding As Mounjaro, Zepbound Generate Nearly $15 Billion Eli Lilly and Co. (NYSE:LLY) stock traded higher Wednesday after the drugmaker reported second-quarter results that topped Wall Street expectations and raised its full-year revenue outlook, driven by continued demand for its diabetes and obesity treatments.
Medical Daily · Aug 5 Opposite Actions on the Same Brain Receptor Both Reduced Food Intake in Mice, Cambridge Team Reports Cambridge researchers found that activating a receptor in the brainstem and blocking it in the hypothalamus both cut food intake in mice.
International Business Times · Aug 5 Eli Lilly Raises Sales Forecast As Weight Loss Drug Demand Soars. Its Stock is Climbing Eli Lilly posted stronger-than-expected second-quarter earnings and revenue, boosted by surging demand for Zepbound and Mounjaro, while its newly launched obesity pill Foundayo made its first contribution to quarterly sales.
Medical Daily · Aug 5 Mouse Study Adds Evidence That Persistent Hunger, Not Willpower, Drives Weight Regain A mouse study found lasting hyperphagia after weight loss, adding to evidence that the body defends a higher weight. Here is what it does and does not show.
Medical Daily · Aug 5 Three Daily Servings of Full-Fat Dairy Did Not Worsen Cholesterol or Body Composition in a 12-Week Trial A 12-week randomized trial of 74 adults found that three daily servings of full-fat dairy did not worsen blood lipids or body composition.
Evening Standard · Aug 5 Mounjaro sales double this year as obesity drug boom prevails, says maker The manufacturer said its obesity medications Mounjaro and Zepbound were driving an acceleration of its overall sales.